InvestorsHub Logo
Followers 173
Posts 5333
Boards Moderated 0
Alias Born 01/03/2014

Re: profstok post# 174364

Tuesday, 03/07/2017 3:47:28 AM

Tuesday, March 07, 2017 3:47:28 AM

Post# of 403102
Imo fairly balanced article..

the article actually takes time to make a critique of the "criticism" of CTIX (Mako articles etc.)

Not sure how the stock will respond.. bottom line.. the author of the article has CTIX on the top of their

"watchlist"

- talks about the current state of the small bio market and how a market cap of only around 100 million actually shows "promise" in the pipeline.

- author thinks our antibiotic platform (of the 3 compounds) is closest to being "investible" - speaks of the very large market potential.

- author has a more "balanced" view about funding for "B" - due to the large market opportunity the author's opinion is that there should be funding opportunities beyond our current financing situation.

- touches on potential dilution.. which brings us back to what we all already know..
for current shareholders securing a partnership might be the ticket to making this a profitable investment at this stage of company development.

Actually refreshing to read criticism that is not wrapped up in FUD..

as an investor I can respect that.

Good luck to all real long shareholders.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News